Girl battling leukemia needs P65K for chemo | Inquirer News
Intensive Care Corner

Girl battling leukemia needs P65K for chemo

NACINO

NACINO

WHEN Allyza Nacino was diagnosed with acute lymphoblastic leukemia in October 2014, she underwent chemotherapy almost every day.

“It was difficult to be away from home for the first time because we stayed in the hospital for a month,” Allyza’s father, Alberto Nacino, a 32-year-old construction worker, told the Inquirer.

Article continues after this advertisement

He said he left his other daughter in the care of his mother in Nueva Ecija so that he could focus his attention on Allyza.

FEATURED STORIES

Now 4 years old, Allyza is doing much better and her doctors at the Philippine Children’s Medical Center say that based on further tests, she may need to undergo chemotherapy either every two weeks or just once a month.

“It is less painful for Allyza but more expensive on our part because it is a 12-cycle program nonetheless. But we got here and for that I am grateful. Allyza has survived so this is not the time to give up,” Nacino said.

Article continues after this advertisement

According to him,

Article continues after this advertisement

Allyza will start her fourth chemotherapy cycle on Aug. 19. Nacino ask Inquirer readers to help them so they may be able to raise the P65,554 needed for the procedure.

Alberto Nacino can be reached at 0907-1917121. Donations can be deposited in his Landbank account (#3676-0047-84).

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Leukemia, Metro, News

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.